Septerna Inc
SEPNHealthcare|Biotechnology|USA
$35.93
-1.91 (-5.05%)
Tangible Book
$8.43
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (19)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Long Daniel D. | SVP, Drug Discovery | 2026-07-01 | SELL | 3,333 | $34.36 | $114.5K |
| Shaikhly Samira | Chief People Officer | 2026-06-29 | SELL | 2,178 | $35.18 | $76.6K |
| Long Daniel D. | SVP, Drug Discovery | 2026-06-22 | SELL | 15,000 | $35.51 | $532.7K |
| Shaikhly Samira | Chief People Officer | 2026-06-12 | SELL | 6,250 | $35.08 | $219.3K |
| Shaikhly Samira | Chief People Officer | 2026-06-01 | SELL | 5,935 | $28.93 | $171.7K |
| Shaikhly Samira | Chief People Officer | 2026-05-26 | SELL | 11,798 | $30.06 | $354.6K |
| Bhatt Elizabeth | President and COO | 2026-04-15 | SELL | 4,000 | $24.34 | $97.4K |
| Shaikhly Samira | Chief People Officer | 2026-03-02 | SELL | 70,453 | $28.1 | $1979.7K |
| Bhatt Elizabeth | President and COO | 2026-02-18 | SELL | 4,000 | $28.97 | $115.9K |
| Long Daniel D. | SVP, Drug Discovery | 2025-11-10 | SELL | 3,501 | $18.06 | $63.2K |
| Ezekowitz Alan | Director | 2025-03-07 | BUY | 13,319 | $6.93 | $92.3K |
| Ezekowitz Alan | Director | 2025-03-06 | BUY | 86,681 | $5.95 | $515.8K |
| Finer Jeffrey | CEO and President | 2025-02-27 | BUY | 17,000 | $5.7 | $96.9K |
| Labrucherie Gil M | CFO | 2025-02-27 | BUY | 10,000 | $5.69 | $56.9K |
| Third Rock Ventures VI, L.P. | 10% Owner | 2025-02-24 | BUY | 18,861 | $6 | $113.2K |
| Third Rock Ventures VI, L.P. | 10% Owner | 2025-02-21 | BUY | 1,040,342 | $5.93 | $6169.2K |
| Labrucherie Gil M | CFO | 2025-02-21 | BUY | 30,000 | $5.74 | $172.2K |
| Third Rock Ventures V, L.P. | 10% Owner | 2024-10-28 | BUY | 650,000 | $18 | $11700K |
| RA Capital Healthcare Fund LP | Director, 10% Owner | 2024-10-28 | BUY | 4,170,000 | $18 | $75060K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked